1. Characterization of contemporary influenza B recombinant viruses harboring mutations of reduced susceptibility to baloxavir marboxil, in vitro and in mice;Abed;Antivir. Res.,2020
2. Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance;Bai,2021
3. Replicative fitness of seasonal influenza A viruses with decreased susceptibility to baloxavir;Chesnokov;J. Infect. Dis.,2020
4. XOFLUZA® (Baloxavir Marboxil) Tablets, for Oral Use,2019
5. Global Update on the Susceptibilities of Human Influenza Viruses to Neuraminidase Inhibitors and the Cap-dependent Endonuclease Inhibitor Baloxavir;Govorkova,2022